Pay in 4 interest-free payments of $7.15 Learn more
Ships within 48 hours · Estimated delivery Aug 18 - Aug 23
The single peptide LY3437943, also known as retatrutide, is currently in development for the treatment of type 2 diabetes and obesity since this medication acts on these receptors
Secondary Side Effects These are not caused directly by GLP-1s but often happen because of common side effects like nausea, vomiting, diarrhea, or rapid weight loss
Diabetes drug tirzepatide has been shown to help people lose almost 16% of their body weight in a clinical trial, and it could soon join semaglutide and liraglutide in the ranks of buzzy weight loss medications on the market
International Journal of Molecular Sciences , 22 (9), 4656
Always check the specific trial's eligibility criteria on ClinicalTrials.gov
After that date, the 4 mg dose moves to $199/month
US$ 25.24
US$ 20.52
US$ 27.62
US$ 25.27
